Target intelligence / Profile preview

Carbonic acid–bicarbonate buffer system

Molecular classification
Other
01

Overview

The **carbonic acid–bicarbonate buffer system** is the major physiological buffering mechanism for maintaining pH balance in human blood and tissues. It involves an equilibrium between dissolved carbon dioxide (CO₂), carbonic acid (H₂CO₃), bicarbonate ion (HCO₃⁻), and hydrogen ion (H⁺). This system is catalyzed by the enzyme carbonic anhydrase and operates according to the equation: CO₂ + H₂O ⇌ H₂CO₃ ⇌ HCO₃⁻ + H⁺. This buffer maintains blood pH tightly around 7.35–7.45, neutralizing excess acids or bases primarily via the interconversion of CO₂ (regulated by the lungs) and HCO₃⁻ (regulated by the kidneys). Dysfunction leads to acid–base disturbances such as metabolic acidosis/alkalosis and respiratory acidosis/alkalosis. Therapeutic manipulation typically targets components of this system, for example, by administering sodium bicarbonate or inhibiting carbonic anhydrase. This is **not a classical molecular target** like an enzyme, receptor, or ion channel, but rather a physiological system; therefore, it is inappropriate to consider it a direct drug target in the conventional sense. Additional notes: The term refers to a **chemical buffering system** rather than a discrete molecular entity (e.g., receptor, enzyme). Drugs may influence or interact with this buffer system, but it is not a molecular drug target itself. Issues may arise when extracting information for drug-target databases, as the system itself is broader than typical targets.

Other names
Bicarbonate buffer systemBicarbonate–carbonic acid buffer systemCarbonic acid–bicarbonate equilibriumH₂CO₃/HCO₃⁻ buffer
02

Mechanism of action

Modulation of blood bicarbonate levels; Inhibition of carbonic anhydrase (affecting equilibrium between CO₂, carbonic acid, and bicarbonate)

03

Biological functions

Acid–base homeostasispH bufferingRegulation of blood pH
04

Disease associations

acid–base imbalancemetabolic acidosismetabolic alkalosisrespiratory acidosisrespiratory alkalosis
05

Safety considerations

Risk of overcorrection to acidemia or alkalemia when intervening pharmacologicallyRespiratory or metabolic compensation limits
06

Interacting drugs

Sodium bicarbonate

2 more in the full profile.

07

Biomarkers

Blood pHSerum bicarbonate (HCO₃⁻)Partial pressure of CO₂ (pCO₂, blood gas)

Beyond the preview

Go deeper on Carbonic acid–bicarbonate buffer system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbonic acid–bicarbonate buffer system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call